(Q28193193)

inferred from title

placebo-controlled trial

1 reference

acute myocardial infarction

inferred from title

1 reference

Z M Chen

1

0 references

H C Pan

2

0 references

Y P Chen

3

0 references

R Peto

4

0 references

R Collins

5

0 references

L X Jiang

6

0 references

J X Xie

7

0 references

L S Liu

Beta blockade during and after myocardial infarction: an overview of the randomized trials

8

0 references

language of work or name

English

0 references

publication date

5 November 2005

0 references

published in

The Lancet

0 references

volume

366

0 references

page(s)

1622-32

0 references

issue

9497

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Expert consensus document on beta-adrenergic receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg Metoprolol Trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Beta-blockers and sudden cardiac death.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Beta blockade, ventricular arrhythmias, and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Task Force on Sudden Cardiac Death of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

1 reference

7 January 2021

Temporal trends in cardiogenic shock complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021

Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967661-1

7 January 2021